Sandeep Sahay, MD, MSc, ATSF

Associate Professor of Medicine, Academic Institute
Associate Clinical Member, Research Institute
Houston Methodist
Weill Cornell Medical College

Description of Research

Pulmonary Hypertension

Pulmonary Arterial Hypertension

Chronic Thromboembolic Pulmonary Hypertension

Pulmonary Embolism

Interstitial Lung Diseases

Areas Of Expertise

Pulmonary fibrosis Pulmonary hypertension Pulmonary arterial hypertension chronic thromboembolic pulmonary hypertension
Education & Training


Safety and efficacy of transitioning from selexipag to oral treprostinil in pulmonary arterial hypertension: Findings from the ADAPT registry
Lachant, D, Minkin, R, Swisher, J, Mogri, M, Zolty, R, Hwang, S, Seaman, S, Broderick, M & Sahay, S 2023, , Pulmonary Pharmacology and Therapeutics, vol. 82, 102232, pp. 102232.

The cascade screening in heritable forms of pulmonary arterial hypertension
Varghese, NP, Padhye, AA, Magoulas, PL, Mallory, GB, Ruiz, FE & Sahay, S 2023, , Pulmonary Circulation, vol. 13, no. 3, e12259.

The role of riociguat in combination therapies for pulmonary arterial hypertension
Rahaghi, FF, Trivieri, MG & Sahay, S 2023, , Respiratory Medicine, vol. 211, 107196, pp. 107196.

Prognosis in Hispanic patient population with pulmonary arterial hypertension: An application of common risk stratification models
Fadah, K, Cruz Rodriguez, JB, Alkhateeb, H, Mukherjee, D, Garcia, H, Schuller, D, Mohammad, KO, Sahay, S & Nickel, NP 2023, , Pulmonary Circulation, vol. 13, no. 2, e12209, pp. e12209.

Insulin-like growth factor binding protein-4: The quest for the breakthrough biomarker in pulmonary arterial hypertension
Estrada, RA & Sahay, S 2023, , Pulmonary Circulation, vol. 13, no. 2, e12252, pp. e12252.

Inhaled Treprostinil Dosage in Pulmonary Hypertension Associated With Interstitial Lung Disease and Its Effects on Clinical Outcomes
Nathan, SD, Deng, C, King, CS, DuBrock, HM, Elwing, J, Rajagopal, S, Rischard, F, Sahay, S, Broderick, M, Shen, E, Smith, P, Tapson, VF & Waxman, AB 2023, , CHEST, vol. 163, no. 2, pp. 398-406.

Effects of COVID-19 pandemic on the management of pulmonary hypertension
Zhou, CY, Sahay, S, Shlobin, O, Soto, FJ, Mathai, SC, Melendres-Groves, L, Mullin, CJ, Levine, DJ, Kay, D, Highland, K, Bossone, E, Poms, A, Memon, H, Balasubramanian, V, Farmer, MJS, Rahaghi, F & Elwing, JM 2023, , Respiratory Medicine, vol. 206, 107061.

Pulmonary hypertension due to high cardiac output
Qaiser, KN, Sahay, S & Tonelli, AR 2023, , Respiratory Medicine, vol. 206, 107034, pp. 107034.

Barriers and facilitators to interhospital transfer of acute pulmonary embolism: An inductive qualitative analysis
DeBerry, J, Rali, P, McDaniel, M, Kabrhel, C, Rosovsky, R, Melamed, R, Friedman, O, Elwing, JM, Balasubramanian, V, Sahay, S, Bossone, E, Farmer, MJS, Klein, AJP, Hamm, ME, Ross, CB & Rivera-Lebron, BN 2023, , Frontiers in Medicine, vol. 10, 1080342, pp. 1080342.

Tobacco, second-hand smoke and cancer
Pinkaew, D, Dammad, T, Bitar, M, Sahay, S & Folz, RJ 2022, . in Environmental Oncology. Springer.

INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH)
the INSPIRE study investigators 2022, , Pulmonary Circulation, vol. 12, no. 3, e12119.

Utilization of risk assessment tools in management of PAH: A PAH provider survey
Sahay, S, Balasubramanian, V, Memon, H, Poms, A, Bossone, E, Highland, K, Kay, D, Levine, DJ, Mullin, CJ, Melendres-Groves, L, Mathai, SC, Soto, FJ, Shlobin, O & Elwing, JM 2022, , Pulmonary Circulation, vol. 12, no. 2, e12057.

BREEZE: Open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension
Spikes, LA, Bajwa, AA, Burger, CD, Desai, SV, Eggert, MS, El-Kersh, KA, Fisher, MR, Johri, S, Joly, JM, Mehta, J, Palevsky, HI, Ramani, GV, Restrepo-Jaramillo, R, Sahay, S, Shah, TG, Deng, C, Miceli, M, Smith, P & Shapiro, SM 2022, , Pulmonary Circulation, vol. 12, no. 2, e12063, pp. e12063.

An adult case of NOTCH3 mutation in pulmonary artery hypertension
Padhye, AA & Sahay, S 2022, , Pulmonary Circulation, vol. 12, no. 1, e12050, pp. e12050.

E-REVEAL Lite 2.0 scoring for early prediction of disease progression in pulmonary arterial hypertension
Sahay, S, Bhatt, J, Beshay, S, Guha, A, Nguyen, DT, Graviss, EA & Nagueh, SF 2022, , Pulmonary Circulation, vol. 12, no. 1, e12026.

Progression of pulmonary veno-occlusive disease without pulmonary hypertension
Beshay, S, Humbert, M, Barrios, R & Sahay, S 2022, , Pulmonary Circulation, vol. 12, no. 1, e12046.

Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study
Rahaghi, FF, Kolaitis, NA, Adegunsoye, A, de Andrade, JA, Flaherty, KR, Lancaster, LH, Lee, JS, Levine, DJ, Preston, IR, Safdar, Z, Saggar, R, Sahay, S, Scholand, MB, Shlobin, OA, Zisman, DA & Nathan, SD 2022, , CHEST, vol. 162, no. 1, pp. 145-155.

Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study
Nathan, SD, Waxman, A, Rajagopal, S, Case, A, Johri, S, DuBrock, H, De La Zerda, DJ, Sahay, S, King, C, Melendres-Groves, L, Smith, P, Shen, E, Edwards, LD, Nelsen, A & Tapson, VF 2021, , The Lancet Respiratory Medicine, vol. 9, no. 11, pp. 1266-1274.

Pulmonary vasodilator treatment in pulmonary hypertension due to left heart or lung disease: time for a high-definition picture?
Piccari, L, Bernardo, RJ, Rodríguez-Chiaradía, D, Vitulo, P, Wort, SJ & Sahay, S 2021, , Pulmonary Circulation, vol. 11, no. 2.

Pregnancy in PAH: Emotions versus reality
Sahay, S & Farber, HW 2021, , Journal of Heart and Lung Transplantation, vol. 40, no. 5, pp. 394-395.